COVID-19 Update: April 1, 2020

In addition to our monthly Wiley Research Headlines, over the coming weeks we will be issuing regular COVID-19 Updates, highlighting recently published articles relating to COVID-19, published by Wiley. Wiley is making all current and future research content and data freely available now. Visit Wiley’s COVID-19 Resource Site to learn more.

• Novel coronavirus treatment with ribavirin: Groundwork for evaluation concerning COVID-19. Journal of Medical Virology. (30 March)

• Repurposing Therapeutic Agents and Herbal Medicines to Defeat Viral Nemesis. Commentary. Drug Development Research. (30 March)

• Review Article: Gastrointestinal features in COVID-19 and the possibility of faecal transmission. Alimentary Pharmacology and Therapeutics. (29 March)

• Early antiviral treatment contributes to alleviate the severity and improve the prognosis of patients with novel coronavirus disease (COVID-19), Journal of Internal Medicine. (27 March)

• Systematic Review of the efficacy and safety of antiretroviral drugs against SARS, MERS, or COVID-19: initial assessment. Review. Journal of the International AIDS Society. (26 March)

• Maternal health care management during the outbreak of coronavirus disease 2019 (COVID-19) Review. Journal of Medical Virology. (26 March)

• Controversial treatments: an updated understanding of the Coronavirus Disease 2019. Review. Journal of Medical Virology. (26 March)

• Covid-19 and the Digestive System. Review Article. Journal of Gastroenterology and Hepatology. (25 March)

• Coronavirus Disease 2019 in Geriatrics and Long-term Care: The ABCDs of COVID-19. Special Article. Journal of the American Geriatrics Society. (25 March)

• Systematic review of COVID-19 in children show milder cases and a better prognosis than adults. Review Article. Acta Paediatrica. (23 March)

About Wiley

Wiley drives the world forward with research and education. Through publishing, platforms and services, we help students, researchers, universities, and corporations to achieve their goals in an ever-changing world. For more than 200 years, we have delivered consistent performance to all of our stakeholders. The Company’s website can be accessed at

/Public Release. The material in this public release comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here.